Interview: DSM-Firmenich innovates with cannabidiol formulations
The pharmaceutical and nutritional products specialist dsm-firmenich aims to make better formulations of cannabidiol (CBD).
Source: outsourcing-pharma.com
Bod Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bod Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bod Science Today - Breaking & Trending Today
Interview: DSM-Firmenich innovates with cannabidiol formulations
The pharmaceutical and nutritional products specialist dsm-firmenich aims to make better formulations of cannabidiol (CBD).
Source: biopharma-reporter.com
Insider Spends AU$149k Buying More Shares In Bod Science
Whilst it may not be a huge deal, we thought it was good to see that the Bod Science Limited ( ASX:BOD ) Non-Executive...
Source: yahoo.com
Bod Unveils Initial Schedule 3 CBD Candidate Trial Results
Australia's Bod Science has provided preliminary top-line results from its phase IIB clinical trial of a potential Schedule 3 CBD medicine.
Source: hempgazette.com
Bod Science Full Year 2023 Earnings: AU$0.056 loss per share (vs AU$0.051 loss in FY 2022)
Bod Science ( ASX:BOD ) Full Year 2023 Results Key Financial Results Revenue: AU$3.64m (down 28% from FY 2022). Net...
Source: yahoo.com